- Wealth Management
- Funds
  - Mutual Funds
  - Alternative Investment Funds
- Structured products
  - Structured Investment products
- Corporate Finance
  - Corporate Finance services
  - Transactions
- Equity Research
- Rewards and incentive plans
  - Rewards and incentive plans
Mutual Funds

Founded alongside the birth of the modern Nordic fixed income and equity capital markets at the end of the 1980s Evli Fund Management Company is today the best fund house in the Nordics, according to both Lipper and Morningstar.
Mutual Funds

Become a customer

Is your need to invest and save independently or do you want help from professionals? You can easily open a customer relationship online with your personal banking codes.
Become a customer
Responsible Evli

Responsible operations enable us to create long-term value and to remain competitive and successful in the changing global operating environment.
Responsible Evli

Responsible investing

Responsibility is at the core of Evli's strategy and is based on transparency and openness.
Responsible investing

Responsible employer

Our approach to responsibility and the way we work are based on Evli’s values: entrepreneurship, valuable relationships, learning, and integrity.
Responsible employer
Insights
- About us
- Offices
- People
- Careers
About us

We draw on our heritage, broad expertise and Nordic values to grow and manage wealth for institutions, corporations and private persons in a responsible way.
About us

Our offices

Evli has offices in Finland and Sweden.
Offices

Our people

Our experts take care of your wealth. We aim to build a long-term relationship with you.
People

Careers

We want to be the best partner for our clients and the number one choice for both current and new employees.
Careers
Become a customer

Investor Relations

My Evli

87 Antibody2c immunoglobulins2c 3d rendering web

Mabtech divested to IK Investment Partners

Name: Evli
Price range: $

Divestment to IK Partners

November 2019

Sector: Healthcare

Service: M&A

Our role

Exclusive financial adviser to the owners of Mabtech on the sale to IK Partners

Buyer

IK Partners is Pan-European private equity firm focused on investments in the Nordics, DACH region, France and Benelux. Since 1989, IK Partners has raised more than EUR 10 billion of capital and invested in over 125 European companies. In connection with the transaction, Merieux Equity Partners acquired a minority stake alongside IK Partners' fund

Target

Mabtech was founded in 1986 and has gained worldwide recognition for its high quality monoclonal antibodies and technical capabilities and is viewed as a pioneer within the growing detection platform techniques ELISpot and FluoroSpot